Final Contract Report (continued)
References
1. Wharam JF, Landon BE, Galbraith
AA, et al. Emergency department use and subsequent hospitalizations among
members of a high-deductible health plan. JAMA 2007;297(10):1093-102.
2. Kaiser Family Foundation. Prescription
drug trends fact sheet; June 2006 Update. Available at:
http://www.kff.org/rxdrugs/3057.cfm. Accessed April 30, 2007.
3. Personal communication with Mark
Cauthen, Risk Supervisor, City of Colorado Springs; June 11, 2007.
4. Jin GZ, Sorensen AT.
Information and consumer choice: the value of publicized
health plan ratings. J Health Econ 2006;25(2):248-75
5. Mukamel DB, Weimer DL, Zwanziger J, et
al Quality report cards, selection of cardiac surgeons, and racial disparities:
a study of the publication of the New York State cardiac surgery reports.
Inquiry 2004;41(4):435-46.
6. Beaulieu ND. Quality information and consumer
health plan choices. J Health Econ 2002;21(1):43-63.
7. Scanlon DP, Chernew ME, McLaughlin, Solon
G. The impact of health plan report cards on managed care enrollment. J
Health Econ 2002;21(1):19-41.
8. Wedig GJ, Tai-Seale M. The effect of report
cards on consumer choice in the health insurance market, J
Health Econ 2002;21(6):1031-48.
9. Chernew M, Scanlon DP. Health plan report
cards and insurance choice. Inquiry 1998;35(1):9-22.
10. Dafny L, Dranove D. Do report
cards tell people anything they don't already know? The case of Medicare
HMOs. NBER Working Paper 2004;1142
11. Chernew ME, Gowrisankaran G, Scanlon
DP. Learning and the value of information: evidence from health plan report
cards. NBER Working Paper 2001 Nov;8589.
12. Dranove D, Kessler D, McClellan M,
Satterthwaite M. Is more information better? The effects of “report
cards” on health care providers. J Political Econ 2003;111:555-88.
13. Arora R, Singer J, Arora A. Influence
of key variables on the patients' choice of a physician. Qual
Manag Health Care 2004;13(3):166-73.
14. Cutler DM, Huckman RS, Landrum MB. The
role of information in medical markets: an analysis of publicly reported
outcomes in cardiac surgery. Am Econ Rev 2004;94(2):342-6.
15. McNamara P. Provider-specific report
cards: a tool for health sector accountability in developing countries. Health
Policy Plan 2006;21(2):101-9.
16. Hibbard JH, Peters E. Supporting informed
consumer health care decisions: data presentation approaches that facilitate
the use of information in choice. Annu Rev Public Health 2003;24:413-33.
17. Hibbard JH, Stockard J, Tusler M. Hospital
performance reports: impact on quality, market share, and reputation. Health
Aff 2005;24(4):1150-60.
18 Newhouse JP. Consumer-directed
health plans and the RAND Health Insurance Experiment. Health
Aff 2004;23(6):107-13.
19. Keeler EB, Brook RH, Goldberg
GA, et al. How free care reduced hypertension in the health insurance experiment.
JAMA 1985;254(14):1926-31.
20. Brook RH, Ware JE Jr, Rogers
WH, et al. Does free care improve adults' health? Results from a randomized
controlled trial. N Engl J Med 1983;309(23):1426-34.
21. Bozic KJ, Smith AR, Hariri
S, et al. The 2007 ABJS Marshall Urist Award: The impact of direct-to-consumer
advertising in orthopaedics. Clin Orthop Relat Res 2007;458:202-19.
22. Dumbleton JH, Manley MT.
Metal-on-metal total hip replacement: what does the literature say? J
Arthroplasty 2005;20(2):174-88.
23. Learmonth ID. Total hip replacement
and the law of diminishing returns. J Bone Joint Surg
Am 2006;88(7):1664-73.
24. Bozic KJ, Morshed S, Silverstein
MD, et al. Use of cost-effectiveness analysis to evaluate new technologies
in orthopaedics. The case of alternative bearing surfaces in total hip arthroplasty. J
Bone Joint Surg Am 2006;88(4):706-14.
25. Mendenhall S. Hip and knee
implant review. Orthop Net News 2007 Jan;1-16.
26. Rowe J, Robinson JC. Consumer-directed
health insurance: the next generation. Interview by James C. Robinson. Health
Aff 2005;Supplement Web Exclusives:W5-583-90.
27. Kane RL, Johnson PE, Town
RJ, Butler M. Economic incentives for preventive care. Rockville, MD: Agency
for Healthcare Research and Quality; August 2004. Evidence Report/Technology
Assessment 101. AHRQ Publication No. 04-0024-2.
28. Cranor CW, Bunting BA, Christensen
DB. The Asheville Project: long-term clinical and economic outcomes of a
community pharmacy diabetes care program. J Am Pharm Assoc 2003;43(2):173-84.
29. Hey K, Perera R. Competitions
and incentives for smoking cessation. Cochrane Database
Syst Rev 2005;2:CD004307.
DOI: 10.1002/14651858.DC004307.pub2.
30. Guiffrida A, Torgerson D.
Should we pay the patient? Review of financial incentives to enhance patient
compliance. Br Med J 1997;20:703-5.
31. Klesges RC, Glasgow RE, Klesges
LM, et al. Competition and relapse prevention training in worksite smoking
modification. Health Educ Res 1987;2(1):5-14.
32. Koffman DM, Lee JW, Hopp JW,
Emont SL. The impact of including incentives and competition in a workplace
smoking cessation program on quit rates. Am J Health Prom 1998;13(2):105-11.
33. Windsor RA, Lowe JB, Bartlett,
EE. The effectiveness of a worksite self-help smoking cessation program:
a randomized trial. J Behav Med 1988;11(4):407-21.
34. Donatelle RJ, Prow SL, Champeau
D, Hudson D. Randomised controlled trial using social support and financial
incentives for high risk pregnant smokers: Significant Other Support (SOS)
program. Tob Control 2000;9(Suppl III):iii67-iii69.
35. Emont SL, Cummings KM. Using
a low-cost, prize-drawing incentive to improve a recruitment rate at a work-site
smoking cessation clinic. J Occup Med 1992;34(8):771-4.
36. Gottlieb NH, Nelson A. A systematic
effort to reduce smoking at the workplace. Health Educ Q 1990;17(1):99-118.
37. Jeffery RW, Forster JL, French
SA, et al. The Healthy Worker Project: a work-site intervention for weight
control and smoking cessation. Am J Pub Health 1993;83(3):395-402.
38. Stitzer ML, Bigelow GE. Contingent
payment for carbon monoxide reduction: effects of pay amount. Behav
Ther 1983;14:647-56.
39. Follick MJ, Fowler JL, Brown
RA. Attrition in worksite weight-loss interventions: the effects of an incentive
procedure. J Consult Clin Psychol 1984;52(1):139-40.
40. Wing RR, Jeffery RW, Pronk
N, Hellerstedt WL. Effects of a personal trainer and financial incentives
on exercise adherence in overweight women in a behavioral weight loss program. Obes
Res 1996;4(5):457-62.
41. Dey P, Foy R, Woodman M, Fullard
B, Gibbs A. Should smoking cessation cost a packet? A pilot randomized controlled
trial of the cost-effectiveness of distributing nicotine therapy free of
charge. Br J Gen Pract 1999;49(439):127-8
42. Hughes JR, Wadland WC, Fenwick
JW, et al. Effect of cost on the self-administration and efficacy of nicotine
gum: a preliminary study. Prev Med 1991;20(4):486-96.
43. Jeffery RW, Forster JL, Baxter
JE, et al. An empirical evaluation of the effectiveness of tangible incentives
in increasing participation and behavior change in a worksite health promotion
program. Am J H Promot 1993;8(2):98-100.
44. Fisher E, Wennberg D, Stukel
T, et al. The implications of regional variations in medicare spending.
Part 2: Health outcomes and satisfaction with care. Ann Intern Med
2003;138(4):289-321.
45. Promoting consumerism through
responsible health care benefit design. Washington, DC: National Business
Coalition on Health; 2006.
46. UnitedHealth premium designation
program; summary of methodology. Minnetonka, MN; 2007.
47. Robinow, A. Consumer incentives;
strong examples in action: patient choice health care. Presented at the
National Business Coalition on Health/Leapfrog Group/Bridges to Excellence
meeting, advancing Value-Driven Health Care: The Third Annual Incentives
and Rewards Symposium. Philadelphia, PA: Buyers Health Care Action Group;
2007 May 15.
48. Briesacher B, Kamal-Bahl,
Hochberg M, Orwig D, Kahler KH. Three-tiered-copayment drug coverage and
use of noonsterodial anti-inflmammatory drugs. Archives of Internal
Medicine. 2004; 164:1679-84.
49. Huskamp HA, Deverka PA, Epstein
AM, et al. The effect of incentive-based formularies on prescription-drug
utilization and spending. N Engl J Med 2003;349(23):2224-32.
50. Huskamp HA, Dverka PA, Epstein
AM, et al. Impact of 3-tier formularies on drug treatment of
attention-deficit/hyperactivity disorder in children. Arch Gen
Psychiatry 2005;62:435-41.
51. Joyce GF, Escarce JJ, Solomon
MD, Goldman DP. Employer drug benefit plans and spending on prescription
drugs. JAMA 2002:288(14):1733-9.
52. Kamal-Bahl S, Briesacher B.
How do incentive-based formularies influence drug selection and spending
for hypertension. Health Aff 2004:23(1):227-36.
53. Schneeweiss S, Walker AM,
Glynn RJ, et al. Outcomes of reference pricing for angiotensin-converting-enzyme
inhibitors. N Engl J Med 2002:346(11):822-9.
54. Schneeweiss S, Soumerai SB,
Maclure M, et al. Clinical and economic consequences of reference pricing
for dihydropyridine calcium channel blockers. Clin Pharmacol
Ther 2003;74(4):388-400.
55. Adams AS, Soumerai SB, Ross-Degnan
D. Use of antihypertensive drugs by Medicare enrollees: does type of drug
coverage matter? Health Aff 2001;20(1):276-86.
56. Goldman DP, Joyce GF, Escarce
JJ, et al. Pharmacy benefits and the use of drugs by the chronically ill.
JAMA 2004;291:2344-50.
57. Piette JD, Heisler M, Wagner
TH. Cost-related medication underuse among chronically ill adults: the
treatments people forgo, how often, and who is at risk. Am J Pub
Health 2004;94(10):1782-7.
58. Tseng C, Brook RH, Keeler
E, et al. Cost-lowering strategies used by Medicare beneficiaries who exceed
drug benefit caps and have a gap in drug coverage. JAMA 2004;292:952-60.
59. Federman AD, Adams AS, Ross-Degnan
D, et al. Supplemental insurance and use of effective cardiovascular drugs
among elderly Medicare beneficiaries with coronary heart disease.
JAMA 2001;286:1732-9.
60. Gibson TB, Mark TL, McGuigan
KA, et al. The effects of prescription drug copayments on statin adherence.
Am J Manag Care 2006;12:509-17.
61. Dormuth CR, Glynn RJ, Neumann
P, et al. Impact of two sequential drug cost-sharing policies on the use
of inhaled medications in older patients with chronic obstructive pulmonary
disease or asthma. Clin Ther 2006;28:964-78.
62. Piette JD, Heisler M, Wagner
TH. Problems paying out-of-pocket medication costs among older adults with
diabetes. Diabetes Care 2004;27:384-91.
63. Piette JD, Wagner TH, Potter
MB, Schillinger D. Health insurance status, cost-related medication underuse,
and outcomes among diabetes patients in three systems of care. Med
Care 2004;42:102-9.
64. Gibson TB, Ozminkowski RJ,
Goetzel RZ. The effects of prescription drug cost sharing: a review of the
evidence. Am J Manag Care 2005;11(11):730-40.
65. Mojtabai R, Olfson M. Medication
costs, adherence and health outcomes among Medicare beneficiaries. Health
Aff 2003;22(4):220-9.
66. Tamblyn R, Laprise R, Hanley
JA, et al. Adverse events associated with prescription drug cost-sharing
among poor and elderly persons. JAMA 2001;285(4):421-9.
67. Heisler M, Langa KM, Eby EL,
et al. The health effects of restricting prescription medication use because
of cost. Med Care 2004;42(7):623-5.
68. Dudley, RA, Rosenthal, MB. Pay
for performance: a decision guide for purchasers. Rockville, MD: Agency for
Healthcare Research and Quality; 2006. AHRQ Publication No. 06-0047. Available at:
http://www.ahrq.gov/qual/p4pguide.htm.
Accessed October 3, 2007.
69. Rosenthal MB, Dudley RA.
Pay-for-performance: will the latest payment trend improve care?
JAMA 2007;297(7):740-4.
70. McGlynn EA. Identifying,
Categorizing, and evaluating healthcare efficiency measures. Prepared for
the Agency for Healthcare Research and Quality, Rockville, MD, under Contract
282-00-0005, Task Order 21; 2007.
71. Kennedy J, Coyne J, Sclar
D. Drug affordability and prescription noncompliance in the United States:
1997-2002. Clin Ther 2004;26(4):607-14.
72. Safran DG, Neuman P, Schoen
C, et al. Prescription drug coverage and seniors: findings from a 2003 national
survey. Health Aff 2005;Web exclusive W5:152-66.
73. Soumerai SB, Pierre-Jacques
M, Zhang F, et al. Cost-related medication nonadherence among elderly and
disabled Medicare beneficiaries : a national survey 1 year before the Medicare
drug benefit. Arch Intern Med 2006;166(17):1829-35.
74. Wilson IB, Rogers WH, Chang
H, Safran DG. Cost-related skipping of medications and other treatments
among Medicare beneficiaries between 1998 and 2000. Results of a national
study. J Gen Intern Med 2005;20(80):715-20.
75. Mojtabai R, Olfson M. Medication
costs, adherence and health outcomes among Medicare beneficiaries. Health
Aff 2003;22(4):220-9.
76. Kennedy J, Morgan S. A cross-national
study of prescription non-adherence due to cost: data from the joint Canada-United
States survey of health. Clin Ther 2006;28:1217-24.
77. Piette JD, Heisler M. The
relationship between older adults' knowledge of their drug coverage and
medication cost problems. J Am Geriatr Soc 2005;54:91-6.
78. Bann CM, Berkman N, Kuo TM.
Insurance knowledge and decision-making practices among Medicare beneficiaries
and their caregivers. Med Care 2004;42:1091-9.
79. McCall N, Rice T, Sangl J.
Consumer knowledge of Medicare and supplemental health insurance benefits.
Health Serv Res 1986:20:633-57.
80. McCormack LA, Uhrig JD. How
does beneficiary knowledge of the Medicare program vary by type of insurance.
Med Care 2003;41:972-8.
81. Garnick DW, Hendricks AM,
Thorpe KE, et al. How well do Americans understand their health coverage? Health
Aff 1993;12(3):204-12.
82. Marquis MS. Consumers' knowledge
about their health insurance coverage. Health Care Financ Rev
1983;5(1):65-79.
83. Hibbard JH, Jewett JJ, Engelmann
S, Tusler M. Can Medicare beneficiaries make informed choices? Health
Aff 1998;17:181-93.
84. Uhrig JD, Bann CM, McCormack
LA, Rudolph N. Beneficiary knowledge of original Medicare and Medicare managed
care. Med Care 2006;44(11) :1020-9 .
85. Meredith LS, Humphrey N, Orlando
M, Camp P. Knowledge of health care benefits among patients with depression. Med
Care 2002;40:338-46.
86. Shrank WH, Fox SA, Kirk A,
et al. The effect of pharmacy benefit design on patient-physician communication
about cost. J Gen Intern Med 2006;21:334-9.
87. Alexander GC, Casalino LP,
Tseng C, et al. Barriers to patient physician communication about out-of-pocket
costs. J Gen Intern Med 2004;19:856-60.
88. Sofaer S, Kreling B, Kenney
E, et al. Family members and friends who help beneficiaries make health
decisions. Health Care Financ Rev 2001:23:105-21.
89. Cihak J. When you're 64; what
consumers don't know about Medicare. Issue Brief. Oakland, CA: California
Health Care Foundation; 2006. Available at:
http://www.chcf.org/documents/insurance/WhenYoure64MedicareIssueBrief.pdf.
Accessed October 3, 2007.
90. Public opinion on Medicare
Part D - the Medicare prescription drug benefit. Kaiser Public Opinion Spotlight.
Washington, DC: Kaiser Family Foundation; 2006. Available at:
http://www.kff.org/spotlight/medicarerx/index.cfm.
Accessed October 3, 2007.
91. O'Connor AM, Legare F, Stacey,
D. Risk communication in practice: the contribution of decision aids. Br
Med J 2003;327(7417):736-40.
92. Hibbard, JH, Peters, E. Supporting
informed consumer health care decisions: data presentation approaches that
facilitate the use of information in choice. Annu Rev Pub Health
2003;24:413-33.
93. Fraenkel L, McGraw, S. What
are the essential elements to enable patient participation in medical decision
making? J Gen Intern Med 2007;22(5):614-9.
94. DeMonaco HJ, von Hippel E.
Reducing medical costs and improving quality via self-management tools.
PLoS Med 4(4): e104; Available at
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040104&ct=1.
Accessed October 3, 2007.
95. Kahneman D, Tversky A. Prospect
theory: an analysis of decision under risk. Econometrica 1979;XLVII:263-91.
96. Personal communication with
Elizabeth H. McNamee, St. Luke's Health Initiatives, Phoenix, AZ;
May 9, 2007.
97. Navigator™ by Tufts
Health Plan Benefit Summary. Watertown, MA: Commonwealth of Massachusetts,
Group Insurance Commission; 2007 March. Available at: http://www.tuftshealthplan.com/pdf/GIC%20Benefit%20Summary_0307_final.pdf.
Accessed on October 11, 2007.
98. Hibbard JH, Stockard J, Tusler
M. Does publicizing hospital performance stimulate quality improvement efforts?
Health Aff 2003;22(2):84-94.
99. Mehrotra A, Grier SA, Dudley
RA. The relationship between health plan advertising and market incentives:
evidence of risk selective behavior. Health Aff 2006;25(3):759-65.
100. Dudley RA, Frolich A,
Robinowitz DL, et al. Strategies to support quality-based purchasing: a
review of the evidence. Rockville, MD: Agency for Healthcare Research and
Quality; 2004. Technical Review 10. AHRQ Publication No. 04-0057.
101. de Brantes F. Best practices
and lessons learned in provider rewards: evidence to date. Presented at
the National Business Coalition on Health/Leapfrog Group Bridges to Excellence
meeting, Advancing Value-Driven Healthcare. Philadelphia, PA; 2007 May 15.
102. Shaller D, Sofaer S, Findlay
SD, et al. Consumers and quality-driven health care: a call to action. Health
Aff 2003;22(2):95-101.
103. Robinson JC. Theory and
practice in the design of physician payment incentives. Milbank Q
2001;79(2):149-77.
104. Sofaer S, Firminger K.
Patient perceptions of the quality of health services. Annu Rev Pub
Health 2005;26:513-59.
105. Hibbard JH, Sofaer S, Jewett
JJ. Condition-specific performance information: assessing salience, comprehension,
and approaches for communicating quality. Health Care Financ Rev
1996;18(1):95-109.
106. Barry MJ, Fowler FJ Jr,
Mulley AG Jr, et al. Patient reactions to a program designed to facilitate
patient participation in treatment decisions for benign prostatic hyperplasia. Med
Care 1995;33(8):771-82.
107. Iglehart JK. Changing health
insurance trends. New Engl J Med 2002; 347:956-62.
108. Herzlinger RE. Let's put
consumers in charge of health care. Harvard Bus Rev 2002;80(7):44-55.
109. Zucker D, Hopkins RS, Sly,
DF, et al. Florida's "truth” campaign: a counter-marketing,
anti-tobacco media campaign 2000: J Pub Health Manage
Pract 2000;6(3):1-6.
110. Williams AF, Wells JK,
Reinfurt DW. Increasing seat belt use in North Carolina. In: Hornik RC,
ed. Public health communication: evidence for behavior change. Mahwah, NJ:
Lawrence Erlbaum; 2002. p. 85-96.
111. Hanson DJ. Social norms
marketing is highly effective. Alcohol Problems and Solutions. Potsdam,
NY: National Social Norms Research Center; 2003. Available at:
http://www2.potsdam.edu/hansondj/YouthIssues/1093546144.html.
Accessed October 3 2007.
112. Nielsen-Bohlman L, Panzer
AM, Kindig DA, eds. Health literacy: a prescription to end the confusion.
Washington, DC: National Academies Press; 2004.
113. Harmon-Jones E, Mills J,
eds. Cognitive dissonance: progress on a pivotal theory in social psychology.
Washington, DC: American Psychological Association; 1999.
114. Gladwell M. The tipping
point: how little things can make a big difference. New York: Little Brown;
2000.
115. Strombom BA, Buchmueller
TC, Feldstein PJ. Switching costs, price sensitivity and health plan choice.
J Health Econ 2002;21(1):89-116.
116. Hibbard JH, Mahoney E,
Stock R, Tusler M. Does increasing patient activation result in improved
self-management behaviors? A further validation of the Patient Activation
Measure (PAM). Health Serv Res 2005;40(6 Pt 1):1918-30.
117. Greene J, Hibbard J, Tusler
M. How much do health literacy and patient activation contribute to older
adults' ability to manage their health? Washington, DC: AARP Public
Policy Institute; June 2005. PPI Publication 2005-05. Available at:
http://assets.aarp.org/rgcenter/health/2005_05_literacy.pdf.
Accessed October 3, 2007.
118. Levinson W, Kao A, Kuby
A, Thisted RA. Not all patients want to participate in decision making:
a national study of public preferences. J Gen Intern Med 2005;20:531-5.
119. Dohan D, Schrag D. Using
navigators to improve care of underserved patients. Cancer 2005;104(4):848-55.
120. Clanton M, Freeman H. Patient
navigator program reduces cancer health disparities. NCI Cancer Bulletin
2004 Aug 17;1(33):1-2. Available at: http://www.cancer.gov/ncicancerbulletin/NCI_Cancer_Bulletin_081704/page3.
Accessed October 7, 2007.
121. Burack JH, Impellizzeri
P, Homel P, Cunningham JN Jr. Public reporting of surgical mortality: a
survey of New York State cardiothoracic surgeons. Ann Thorac Surg
1999;68(4):1195-200.
122. Werner RM, Asch DA. The
unintended consequences of publicly reporting quality information. JAMA
2005;293(10):1239-44.
Return to Contents
Current as of November 2007
AHRQ Publication No. 07(08)-0059
Internet Citation:
Final Contract Report. Consumer Financial Incentives: A Decision
Guide for Purchasers. AHRQ Publication No. 07(08)-0059. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/qual/value/incentives.htm
540 Gaither Road Rockville, MD 20850